An interventional study of Dynamic Vessel Analyzer (DVA) and Fourier Domain Doppler Optical Coherence Tomography (FDOCT) in Anterior Ischemic Optic Neuropathy, sponsored by Medical University of Vienna. Completed at 1 site in Austria. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-09-01.
Sponsored by Medical University of Vienna · Not applicable, Interventional, and Basic science
Ischemic optic neuropathy is among the most common causes of serious impaired vision in the middle-aged and elderly population in the western world. The current study focuses on a subgroup of ischemic optic neuropathy, the so-called non-arteritic ischemic optic neuropathy (NAION). Although the exact pathogenesis of NAION has not been fully clarified it is known that patients with cardio-vascular risk factors such as hypertension, diabetes mellitus and dyslipidemia have also an increased risk to develop NAION. Along this line of thought it has been shown that patients with a history of NAION in one eye have an increased risk to develop NAION also on the contralateral eye. However, clinical studies investigating ocular perfusion abnormalities in patients with NAION are sparse and even contradicting. Thus, the current study seeks to measure ocular blood flow parameters in patients with a history of NAION and compare it to healthy age-matched subjects.
Inclusion criteria for healthy subjects:
Inclusion criteria for patients with NAION:
Any of the following will exclude a healthy subject from the study:
Any of the following will exclude a patient from the study:
patients with a history of non-arteritic anterior ischemic optic neuropathy (NAION) in one eye
Device: Dynamic Vessel Analyzer (DVA) · Device: Fourier Domain Doppler Optical Coherence Tomography (FDOCT) · Device: Optical coherence tomography (OCT)
healthy age-and sex- matched control subjects
Device: Dynamic Vessel Analyzer (DVA) · Device: Fourier Domain Doppler Optical Coherence Tomography (FDOCT) · Device: Optical coherence tomography (OCT)
Retinal vessel diameters and oxygen saturation will be measured with the DVA device.
Retinal blood flow will be assessed using FDOCT.
Nerve fiber layer thickness and central retinal thickness will be measured using OCT.
Flicker light induced hyperemia in retinal vessels
Response of retinal vessels to increased neuronal activity assessed with flicker light
Time frame: 1 day
Retinal vessel diameters
Response of retinal vessel diameters to flicker light assessed with DVA
Time frame: 1 day
Retinal oxygen saturation
Retinal oxygen saturation measured with DVA
Time frame: 1 day
Retinal blood flow
Response of retinal blood flow to flicker light assessed with FDOCT
Time frame: 1 day
Retinal nerve fiber layer thickness
Retinal nerve fiber layer thickness measured using OCT
Time frame: 1 day
Central retinal thickness
Central retinal thickness using OCT
Time frame: 1 day
This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical University of Vienna